7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Amdocs Still Neutral

by Zacks Equity Research

December 05, 2011 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We reiterate our long-term Neutral recommendation on Amdocs Ltd. ( DOX - Analyst Report ) . The company’s fourth quarter of fiscal 2011 financial results met the Zacks Consensus Estimates. Amdocs enjoys a strong portfolio of several industry-leading technology integration products for managed services and large transformational projects.Amdocs benefited from the long-term trend toward information technology outsourcing.

We believe consolidation of the telecom industry may act as a growth catalyst for the company. Historically, Amdocs is a major beneficiary of the merger among the big U.S. telecom carriers. We also believe the long-term fundamentals of Amdocs remain firm mainly due to the transition of telecom service providers to converged IP solutions. However, in the near term, the company may suffer due to higher expenses for productivity improvement and prolonged global economic volatility.

Amdocs recently completed the acquisition of Bridgewater Systems of Canada, a leading intelligent software developer for converged mobile platform. Bridgewater’s software optimized mobile data growth, reduces network congestion by diverting data traffic to WiFi networks while enabling wireless service providers to migrate from 2G to 3G or next-generation 4G networks. Bridgewater serves more than 150 wireless operators throughout the world. Important among them are giants such as Verizon Wireless, which is a joint venture between Verizon Communications Inc. ( VZ - Analyst Report ) and Vodafone Group plc. ( VOD - Analyst Report ) , Sprint Nextel Corp. ( S - Analyst Report ) , Bell Mobility, Telstra, and Etihad Etisalat (Mobily).

Acquisition of Bridgewaterwill help Amdocs to enhance its phone-billing software especially its Customer Experience Systems (CES 8) product suit. For broadband, this software provides a single platform capable of supporting complex requirements of traditional and next- generation triple-play voice, video, and data services as it focuses on addressing favorable market trends in the communications industry.

This solution facilitates carriers to effectively monetize their assets, deliver superior services and improve its operating performance. Using Amdocs with integrated Bridgewater software enable wireless carriers to offer innovative pricing strategy for data plans. While enabling its customers to offer personalized value-based pricing strategy, Amdocs can now move one step forward compared with its rivals, such as Comverse Technologies Inc, Convergys Corp. ( CVG - Snapshot Report ) , and Tekelec ( ) .

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.